Precision Biosciences DTIL
NASDAQ DTIL
$9.15 -0.35 (-3.68%)
At close: Nov 11, 2026 · 4:00 PM EST

Precision Biosciences (DTIL) Non Operating Interest Expenses (2019 - 2026)

Updated

Precision Biosciences (DTIL) posted Non Operating Interest Expenses of $307,000 for fiscal Q3 2026 (quarter ended Sep 30, 2026), down 15.2% from $362,000 a year earlier but up 2.3% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Non Operating Interest Expenses at Precision Biosciences was $1.27 million, down 13.6% year-over-year; for FY2025 (ended Dec 31, 2025), it came in at $1.42 million, down 20.2% from FY2024.

  • Annual Non Operating Interest Expenses shows a four-year compound annual growth rate of 81.2% (FY2021 to FY2025).
  • In prior fiscal years, Precision Biosciences' Non Operating Interest Expenses was $1.78 million in FY2024 (-20.1%), $2.23 million in FY2023 (+100.7%), $1.11 million in FY2022 (+741.7%) and $132,000 in FY2021.
  • Quarterly Non Operating Interest Expenses has run from a low of $42,000 in fiscal Q1 2022 to a high of $579,000 in fiscal Q4 2023 over five years.
  • On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last four quarters, with an average decline of 15.0% over the last eight quarters.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was fiscal Q4 2022, with growth of 817.0%; the weakest was fiscal Q3 2024, with a decline of 55.6%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior fiscal quarters was $300,000 (Q2 2026), $311,000 (Q1 2026) and $348,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Precision Biosciences 264.98 Mn -121.18 Mn - 307,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 307,000.00
Jun 30, 2026 300,000.00
Mar 31, 2026 311,000.00
Dec 31, 2025 348,000.00
Sep 30, 2025 362,000.00
Jun 30, 2025 358,000.00
Mar 31, 2025 354,000.00
Dec 31, 2024 392,000.00
Sep 30, 2024 256,000.00
Jun 30, 2024 560,000.00
Mar 31, 2024 574,000.00
Dec 31, 2023 579,000.00
Sep 30, 2023 576,000.00
Jun 30, 2023 553,000.00
Mar 31, 2023 522,000.00
Dec 31, 2022 486,000.00
Sep 30, 2022 405,000.00
Jun 30, 2022 178,000.00
Mar 31, 2022 42,000.00
Dec 31, 2021 53,000.00
API Access

Precision Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=DTIL&period=max&api_key=YOUR_API_KEY